SCHEDULE: Deep Track Capital Reports 4.74% Stake in Cybin Inc.
Beneficial Ownership Report
Deep Track Capital, LP, along with Deep Track Biotechnology Master Fund, Ltd. and David Kroin, reported a 4.74% beneficial ownership stake in Cybin Inc. as of December 31, 2025.
Summary
- Deep Track Capital, LP, Deep Track Biotechnology Master Fund, Ltd., and David Kroin collectively reported beneficial ownership of 2,391,505 common shares of Cybin Inc.
- This ownership represents 4.74% of Cybin Inc.'s common shares outstanding.
- The calculation of beneficial ownership is based on 50,431,381 shares, which includes 49,894,131 common shares outstanding as of December 19, 2025, and 537,250 exercisable warrants.
- The 537,250 warrants are exercisable into common stock, subject to a 9.99% maximum percentage exercise limitation, preventing the holder from exceeding this threshold of outstanding common stock after exercise.
- The reporting persons certified that the securities were not acquired and are not held for the purpose of changing or influencing the control of Cybin Inc.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral disclosure, providing factual information about an institutional investor's stake without indicating any specific positive or negative operational developments for Cybin Inc.
Positives
- Institutional investment by Deep Track Capital, LP and Deep Track Biotechnology Master Fund, Ltd. indicates a level of confidence in Cybin Inc.
Future Outlook
The filing does not contain any forward-looking statements or guidance from Cybin Inc. or the reporting persons regarding Cybin Inc.'s future performance.
Management Comments
- David Kroin, Managing Member of the General Partner of the Investment Adviser (Deep Track Capital, LP) and Director (Deep Track Biotechnology Master Fund, Ltd.), certified that the securities were not acquired to change or influence control of the issuer.
Industry Context
StockSavvy.ai notes that institutional filings like Schedule 13G provide transparency into significant ownership stakes, which can sometimes signal institutional confidence or strategic positioning within the biotechnology sector.
Stakeholder Impact
- Shareholders: Increased transparency regarding institutional ownership in Cybin Inc.
Key Dates
| Date | Description |
|---|---|
| 12/19/2025 | Date of issuer's F-10 filing, stating 49,894,131 common shares outstanding. |
| 12/31/2025 | Date of event which requires filing of this statement (beneficial ownership calculation date). |
| 02/13/2026 | Date of signing and filing of this Schedule 13G Amendment No. 1. |
Keywords
Cybin Inc., Deep Track Capital, Deep Track Biotechnology Master Fund, David Kroin, Schedule 13G, beneficial ownership, common shares, institutional investment, biotechnology
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.